FDA Label for Myderm Numbing Roll-on
View Indications, Usage & Precautions
Myderm Numbing Roll-on Product Label
The following document was submitted to the FDA by the labeler of this product Inspec Solutions Llc.. The document includes published materials associated whith this product with the essential scientific information about this product as well as other prescribing information. Product labels may durg indications and usage, generic names, contraindications, active ingredients, strength dosage, routes of administration, appearance, warnings, inactive ingredients, etc.
Otc - Active Ingredient
Active Ingredient
Lidocaine HCI 5%
Otc - Purpose
Uses Helps relieve anorectal symptoms (pain, soreness, burning, itching). Temporarily reduces the swelling associated with irritated hemorrhoidal tissue and other anorectal disorders.
Warnings
Warnings For external use only
Otc - When Using
When using this product • avoid contact with the eyes or mucous membranes.
Otc - Stop Use
Stop use and ask doctor if • condition worsens, or if symptoms persist for more than 7 days, or dear up and reoccur again within a few days. Do not use if pregnant or breast-feeding.
Otc - Keep Out Of Reach Of Children
Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center immediately.
Pregnancy
Do not use if pregnant or breast-feeding.
Indications & Usage
Directions • Adults and children 2 years of age and older: Apply to affected area not more than 3 to 4 times daily. • Children under 2
Inactive Ingredient
Inactive Ingredients Crosspolymer, Aloe Barbadensis Leaf Extract, Aminomethyl Propanol,
C30-45 Alkyl Cetearyl Dimethicone Crosspolymer, Caprylyl
Methicone, Cetearyl Alcohol, Ceteth-20 Phosphate, Dicetyl
Phosphate, Dimethicone, Disodium EDTA, Ethylhexylglycerin, Glyceryl
Stearate, Phenoxyethanol, SD Alcohol 40, Steareth-21 , Water.
Package Label.Principal Display Panel
* Please review the disclaimer below.
